跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-221
首页
药物
A-221
A-221
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE
申请人: UNIV WASHINGTON
优先权: 2015
CN
EP
US
WO
9 件公开
ENDOGLYCOSIDASE MUTANTS FOR GLYCOPROTEIN REMODELING AND METHODS OF USING IT
申请人: CHO PHARMA INC
优先权: 2016
CN
EP
US
WO
7 件公开
Compound and method for treatment of alzheimer's disease
申请人: ALPHABETA AB
优先权: 2020
CN
EP
US
WO
5 件公开
Materials and methods useful for affecting tumor cell growth, migration and invasion
申请人: CROCE CARLO M
优先权: 2010
CN
US
5 件公开
ANTI-INFLAMMATORY PEPTIDES, AND USES THEREOF
申请人: NURITAS LTD
优先权: 2015
EP
US
5 件公开
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
申请人: EMMANUEL EYAL
优先权: 2008
US
5 件公开
ONCOLYTIC VIRUS AND USE THEREOF
申请人: JOINT BIOSCIENCES SH LTD
优先权: 2021
CN
EP
US
WO
4 件公开
Shaped catalyst body for partial oxidation reactions
申请人: SUED CHEMIE AG
优先权: 2005
EP
US
WO
4 件公开
Anti-folate receptor alpha antibody conjugated with hemiasterlins
申请人: SUTRO BIOPHARMA INC
优先权: 2017
US
WO
4 件公开
Method and device for cooling a hot reactor gas, for example in the production of phthalic anhydride
申请人: WILKE ALFED
优先权: 1999
US
4 件公开
第 1 / 8 页
上一页
下一页
药物
反馈